{
    "info": {
        "nct_id": "NCT06560645",
        "official_title": "A Phase 1 Open-Label, Multi-Center, Safety and Efficacy Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4",
        "inclusion_criteria": "* Willing and able to comply with all scheduled visits, treatment plan, laboratory tests, lifestyle considerations (including contraception requirements), and other study procedures\n* Histologically confirmed advanced, recurrent, or metastatic solid tumor malignancy with any mutation of SMARCA4 by local testing that has either progressed on or is ineligible for standard of care therapy\n* Must have measurable or non-measurable (but evaluable) disease per RECIST v1.1\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1\n* Willing to provide either archival or fresh tumor tissue sample\n* Adequate organ function (hematology, renal, and hepatic)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Participants with solid tumors with known concomitant SMARCA2 mutation or loss of protein expression\n* Clinically significant or uncontrolled cardiac disease, uncontrolled electrolyte disorders, uncontrolled or symptomatic central nervous system (CNS) metastases or leptomeningeal disease\n* History of another malignancy within 3 years except for adequately treated basal cell or squamous cell skin cancer, superficial bladder cancer, prostate intraepithelial neoplasm, carcinoma in situ of the cervix, or other non-invasive or indolent malignancies, or malignancies previously treated with curative intent and not on active therapy or expected to require treatment or recurrence during the study\n* Receipt of any targeted therapy directed against BRM/BRG1 (SMARCA2/SMARCA4).",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Willing to provide either archival or fresh tumor tissue sample",
            "criterions": [
                {
                    "exact_snippets": "Willing to provide either archival or fresh tumor tissue sample",
                    "criterion": "tumor tissue sample",
                    "requirements": [
                        {
                            "requirement_type": "willingness to provide",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "sample type",
                            "expected_value": [
                                "archival",
                                "fresh"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Willing and able to comply with all scheduled visits, treatment plan, laboratory tests, lifestyle considerations (including contraception requirements), and other study procedures",
            "criterions": [
                {
                    "exact_snippets": "Willing and able to comply with all scheduled visits",
                    "criterion": "compliance with scheduled visits",
                    "requirements": [
                        {
                            "requirement_type": "willingness and ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Willing and able to comply with ... treatment plan",
                    "criterion": "compliance with treatment plan",
                    "requirements": [
                        {
                            "requirement_type": "willingness and ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Willing and able to comply with ... laboratory tests",
                    "criterion": "compliance with laboratory tests",
                    "requirements": [
                        {
                            "requirement_type": "willingness and ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Willing and able to comply with ... lifestyle considerations (including contraception requirements)",
                    "criterion": "compliance with lifestyle considerations (including contraception requirements)",
                    "requirements": [
                        {
                            "requirement_type": "willingness and ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Willing and able to comply with ... other study procedures",
                    "criterion": "compliance with other study procedures",
                    "requirements": [
                        {
                            "requirement_type": "willingness and ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Must have measurable or non-measurable (but evaluable) disease per RECIST v1.1",
            "criterions": [
                {
                    "exact_snippets": "Must have measurable or non-measurable (but evaluable) disease per RECIST v1.1",
                    "criterion": "disease status per RECIST v1.1",
                    "requirements": [
                        {
                            "requirement_type": "measurability",
                            "expected_value": [
                                "measurable",
                                "non-measurable (but evaluable)"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate organ function (hematology, renal, and hepatic)",
            "criterions": [
                {
                    "exact_snippets": "Adequate organ function (hematology, renal, and hepatic)",
                    "criterion": "hematologic function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate organ function (hematology, renal, and hepatic)",
                    "criterion": "renal function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate organ function (hematology, renal, and hepatic)",
                    "criterion": "hepatic function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Histologically confirmed advanced, recurrent, or metastatic solid tumor malignancy with any mutation of SMARCA4 by local testing that has either progressed on or is ineligible for standard of care therapy",
            "criterions": [
                {
                    "exact_snippets": "Histologically confirmed advanced, recurrent, or metastatic solid tumor malignancy",
                    "criterion": "solid tumor malignancy",
                    "requirements": [
                        {
                            "requirement_type": "histological confirmation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "advanced",
                                "recurrent",
                                "metastatic"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "any mutation of SMARCA4 by local testing",
                    "criterion": "SMARCA4 mutation",
                    "requirements": [
                        {
                            "requirement_type": "mutation presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "has either progressed on or is ineligible for standard of care therapy",
                    "criterion": "standard of care therapy",
                    "requirements": [
                        {
                            "requirement_type": "progression on therapy or ineligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Participants with solid tumors with known concomitant SMARCA2 mutation or loss of protein expression",
            "criterions": [
                {
                    "exact_snippets": "solid tumors",
                    "criterion": "solid tumor",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "known concomitant SMARCA2 mutation or loss of protein expression",
                    "criterion": "SMARCA2",
                    "requirements": [
                        {
                            "requirement_type": "mutation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "protein expression",
                            "expected_value": "loss"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Clinically significant or uncontrolled cardiac disease, uncontrolled electrolyte disorders, uncontrolled or symptomatic central nervous system (CNS) metastases or leptomeningeal disease",
            "criterions": [
                {
                    "exact_snippets": "Clinically significant or uncontrolled cardiac disease",
                    "criterion": "cardiac disease",
                    "requirements": [
                        {
                            "requirement_type": "clinical significance or control",
                            "expected_value": "clinically significant or uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "uncontrolled electrolyte disorders",
                    "criterion": "electrolyte disorders",
                    "requirements": [
                        {
                            "requirement_type": "control",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "uncontrolled or symptomatic central nervous system (CNS) metastases",
                    "criterion": "central nervous system (CNS) metastases",
                    "requirements": [
                        {
                            "requirement_type": "control or symptoms",
                            "expected_value": "uncontrolled or symptomatic"
                        }
                    ]
                },
                {
                    "exact_snippets": "leptomeningeal disease",
                    "criterion": "leptomeningeal disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Receipt of any targeted therapy directed against BRM/BRG1 (SMARCA2/SMARCA4).",
            "criterions": [
                {
                    "exact_snippets": "Receipt of any targeted therapy directed against BRM/BRG1 (SMARCA2/SMARCA4)",
                    "criterion": "targeted therapy directed against BRM/BRG1 (SMARCA2/SMARCA4)",
                    "requirements": [
                        {
                            "requirement_type": "receipt",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of another malignancy within 3 years except for adequately treated basal cell or squamous cell skin cancer, superficial bladder cancer, prostate intraepithelial neoplasm, carcinoma in situ of the cervix, or other non-invasive or indolent malignancies, or malignancies previously treated with curative intent and not on active therapy or expected to require treatment or recurrence during the study",
            "criterions": [
                {
                    "exact_snippets": "History of another malignancy within 3 years",
                    "criterion": "history of another malignancy",
                    "requirements": [
                        {
                            "requirement_type": "time since diagnosis",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "except for adequately treated basal cell or squamous cell skin cancer",
                    "criterion": "basal cell or squamous cell skin cancer",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "adequately treated"
                        }
                    ]
                },
                {
                    "exact_snippets": "except for ... superficial bladder cancer",
                    "criterion": "superficial bladder cancer",
                    "requirements": [
                        {
                            "requirement_type": "exclusion",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "except for ... prostate intraepithelial neoplasm",
                    "criterion": "prostate intraepithelial neoplasm",
                    "requirements": [
                        {
                            "requirement_type": "exclusion",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "except for ... carcinoma in situ of the cervix",
                    "criterion": "carcinoma in situ of the cervix",
                    "requirements": [
                        {
                            "requirement_type": "exclusion",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "except for ... other non-invasive or indolent malignancies",
                    "criterion": "other non-invasive or indolent malignancies",
                    "requirements": [
                        {
                            "requirement_type": "exclusion",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "malignancies previously treated with curative intent and not on active therapy or expected to require treatment or recurrence during the study",
                    "criterion": "malignancies previously treated with curative intent",
                    "requirements": [
                        {
                            "requirement_type": "treatment intent",
                            "expected_value": "curative"
                        },
                        {
                            "requirement_type": "active therapy status",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "expected need for treatment or recurrence during the study",
                            "expected_value": false
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}